Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Vivera Pharmaceuticals.

    Client Virtual Booth

    VIVERA PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Vivera Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4533 MacArthur Blvd 5049 Newport Beach, California 92660
    Telephone
    Telephone
    1.844.484.8372
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://viverapharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viverapharmaceuticals
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    TABMELT Granted Patent Allowance in Israel, Expanding Vivera's Global Licensing Reach

    Details:

    TABMELT is a novel patented and patent-pending sublingual drug delivery system that allows patients to take a medication by dissolving a tablet under their tongue.


    Lead Product(s): Undisclosed

    Therapeutic Area: Neurology Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 27, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Vivera Partners with NINDS of NIH to Identify Potential Stuttering Treatments

    Details:

    The collaboration may be an initial step toward developing novel and personalized therapeutic approaches for changing the course of the disorder for people who stutter including its lead asset VVRA – TM 008.


    Lead Product(s): VVRA–TM 008

    Therapeutic Area: Neurology Product Name: VVRA–TM 008

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: National Institute of Neurological Disorders and Stroke

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration May 17, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search